SEOM clinical guidelines on cardiovascular toxicity (2018)


Por: Virizuela J, Garcia A, de las Penas R, Santaballa A, Andres R, Beato C, de la Cruz S, Gavila J, Gonzalez-Santiago S, Fernandez T

Publicada: 1 ene 2019
Resumen:
One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients.

Filiaciones:
Virizuela J:
 Complejo Hosp Reg Virgen Macarena, Serv Oncol Med, Av Doctor Fedriani 3, Seville 41009, Spain

Garcia A:
 Complejo Asistencial Univ Salamanca CAUSA, Inst Invest Biomed Salamanca IBSAL, Serv Cardiol, Ciber CV, Salamanca, Spain

de las Penas R:
 Hosp Prov Castellon, Serv Oncol Med, Castellon de La Plana, Spain

Santaballa A:
 Hosp Univ & Politecn La Fe, Serv Oncol Med, Valencia, Spain

Andres R:
 Hosp Clin Univ Lozano Blesa, Serv Oncol Med, Zaragoza, Spain

Beato C:
 Complejo Hosp Reg Virgen Macarena, Serv Oncol Med, Seville, Spain

de la Cruz S:
 Complejo Hosp Navarra, Serv Oncol Med, Pamplona, Spain

Gavila J:
 Fdn Inst Valenciano Oncol IVO, Serv Oncol Med, Valencia, Spain

Gonzalez-Santiago S:
 Complejo Hosp Univ Caceres, Serv Oncol Med, Caceres, Spain

Fernandez T:
 Hosp Univ La Paz, IdiPAZ, CiberCV, Serv Cardiol, Madrid, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 21 Número: 1
Páginas: 94-105
WOS Id: 000456179300010
ID de PubMed: 30627982

MÉTRICAS